Cidara Therapeutics Cash from Investing (TTM)

Cidara Therapeutics Inc (CDTX)

0.6297

-0.03 (-4.59%) USD | NASDAQ | Aug 11, 16:00

0.6297 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
March 31, 2022	-0.113M
December 31, 2021	-0.041M
September 30, 2021	-0.041M
June 30, 2021	-0.083M
March 31, 2021	-0.162M
December 31, 2020	-0.186M
September 30, 2020	-0.186M
June 30, 2020	-0.132M
March 31, 2020	-0.062M
December 31, 2019	-0.035M
September 30, 2019	4.425M
June 30, 2019	14.11M
March 31, 2019	13.84M
December 31, 2018	14.30M
September 30, 2018	5.058M

Date	Value
June 30, 2018	-14.50M
March 31, 2018	-6.362M
December 31, 2017	4.471M
September 30, 2017	44.64M
June 30, 2017	57.61M
March 31, 2017	36.78M
December 31, 2016	25.48M
September 30, 2016	-5.346M
June 30, 2016	-58.93M
March 31, 2016	-46.07M
December 31, 2015	-46.09M
September 30, 2015	-50.79M
June 30, 2015	-0.47M
March 31, 2015	-1.021M
December 31, 2014	-0.991M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-14.50M

Minimum

Jun 2018

44.64M

Maximum

Sep 2017

4.155M

Average

-0.041M

Median

Sep 2021

Cash from Investing (TTM) Benchmarks